Filing Details
- Accession Number:
- 0001209191-16-114141
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-04-13 18:32:24
- Reporting Period:
- 2016-04-11
- Filing Date:
- 2016-04-13
- Accepted Time:
- 2016-04-13 18:32:24
- Original Submission Date:
- 2016-04-12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1339970 | Atyr Pharma Inc | LIFE | () | 4/A |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236447 | Paul Schimmel | 3545 John Hopkins Court, Suite #250 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-04-11 | 5,259 | $3.59 | 17,831 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-04-11 | 5,300 | $3.45 | 211,481 | No | 4 | P | Indirect | See Footnote |
Common Stock | Acquisiton | 2016-04-11 | 22,100 | $3.59 | 233,581 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 634,242 | Indirect | See Footnote |
Footnotes
- Represents the weighted average price for the shares. The shares were purchased at prices ranging from $3.58 per share to $3.60 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price for the shares. The shares were purchased at prices ranging from $3.44 per share to $3.45 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- Certain of the shares of Common stock were inadvertently reported as being directly held by the Reporting Person rather than indirectly held by the Paul R. Schimmel Prototype PSP
- These shares are owned directly by Paul R. Schimmel Prototype PSP. The Reporting Person is the trustee of the Paul R. Schimmel Prototype PSP.
- These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U.A Dtd 9/6/2000.